Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells

Hypertension

Volumn 45, Issue 4 SUPPL., 2005, Pages 804-810

  Zeng, Chunyu ^a,b   Yang, Zhiwei ^b   Wang, Zheng ^b   Jones, John ^b   Wang, Xiaoyan ^b   Altea, Joanna ^b   Mangrum, Amy J ^c   Hopfer, Ulrich ^d   Sibley, David R ^e   Eisner, Gilbert M ^b   Felder, Robin A ^c   Jose, Pedro A ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Kidney; Normotension; Rats, spontaneously hypertensive; Receptors, angiotensin II; Receptors, dopamine

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DOPAMINE 5 RECEPTOR;

ANALYSIS OF VARIANCE; BLOOD PRESSURE; BRUSH BORDER; CELL CULTURE; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HYPERTENSION; IMMUNOBLOTTING; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WILD TYPE;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; DRUG INTERACTIONS; KIDNEY TUBULES, PROXIMAL; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; TISSUE DISTRIBUTION;

EID: 20144384993     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000155212.33212.99     Document Type: Conference Paper

References (53)

1. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther. 1998;80:149-182.
2. Gurley SB, Le TH, Coffman TM. Gene-targeting studies of the renin-angiotensin system: mechanisms of hypertension and cardiovascular disease. Cold Spring Harbor Symp Quant Biol. 2002;67:451-457.
3. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension. 2002;39:316-322.
4. Hall JE, Brands MW, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol. 1999;10(suppl 12):S258-S265.
5. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics. 2004;19:233-246.
6. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol. 2000;62:621-647.
7. Carey RM. Theodore Cooper Lecture: renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension. 2001;38:297-302.
8. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension. 1998;32:187-197.
9. Chen C, Lokhandwala MF. Potentiation by enalaprilat of fenoldopamevoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats. Naunyn-Schmiedebergs Arch Pharmacol. 1995;352:194-200.
10. Hussain T, Abdul-Wahab R, Kotak DK, Lokhandwala MF. Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension. 1998;32:1054-1059.
11. Efendiev R, Budu CE, Cinelli AR, Bertorello AM, Pedemonte CH. Intracellular Na+ regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J Biol Chem. 2003;278:28719-28726.
12. Luippold G, Max A, Albinus M, Osswald H, Muhlbauer B. Role of the renin-angiotensin system in the compensation of quinpirole-induced blood pressure decrease. Naunyn-Schmiedebergs Arch Pharmacol. 2003;367:427-433.
13. Yamaguchi I, Yao L, Sanada H, Ozono R, Mouradian MM, Carey RM, Jose PA, Felder RA. Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Hypertension. 1997;29:962-968.
14. Cheng HF, Becker BN, Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest. 1996;97:2745-2752.
15. Zeng C, Luo Y, Asico LD, Hopfer U, Eisner GM, Felder RA, Jose PA. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension. 2003;42:787-792.
16. Zeng C, Asico LD, Wang X, Hopfer U, Eisner GM, Felder RA, Jose PA. Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of spontaneously hypertensive rats. Hypertension. 2003;41:724-729.
17. 1 angiotensin receptor. J Am Soc Nephrol. 2001;12:477A Abstract.
18. 1 dopamine receptors in renal proximal tubule cells from spontaneously hypertensive rats. J Am Soc Nephrol. 2002;13:148A Abstract.
19. Zeng C, Wang D, Yang Z, Wang Z, Asico LD, Wilcox CS, Eisner GM, Welch WJ, Felder RA, Jose PA. D1 dopamine receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension. 2004;43:673-679.
20. Mangrum AJ, Gomez RA, Norwood VF. Effects of AT(1A) receptor deletion on blood pressure and sodium excretion during altered dietary salt intake. Am J Physiol Renal Physiol. 2002;283:F447-F453.
21. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A. 1995;92:3521-3525.
22. Holmes A, Hollon TR, Gleason TC, Liu Z, Dreiling J, Sibley DR, Crawley JN. Behavioral characterization of dopamine D5 receptor null mutant mice. Behav Neurosci. 2001;115:1129-1144.
23. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS III, Westphal H, Jose PA, Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci. 2002;22:10801-10810.
24. 2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1071-R1078.
25. Albrecht FE, Xu J, Moe OW, Hopfer U, Simonds WF, Orlowski J, Jose PA. Regulation of NHE3 activity by G-protein subunits in renal brush-border membranes. Am J Physiol Regul Integr Comp Physiol. 2000;278:R1064-R1073.
26. + exchanger interactions in the kidney in hypertension. Hypertension. 2000;36:395-399.
27. Yu P-Y, Asico LD, Eisner GM, Hopfer LT, Felder RA, Jose PA. Renal protein phosphatase 2A activity and spontaneous hypertension in rats. Hypertension. 2000;36:1053-1058.
28. Privratsky JR, Wold LE, Sowers JR, Quinn MT, Ren J. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension. 2003;42:206-212.
29. Zheng S, Yu P, Zeng C, Wang Z, Yang Z, Andrews PM, Felder RA, Jose PA. Gα12- and Gα13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension. 2003;41:604-610.
30. Schelling JR, Linas SL. Angiotensin II-dependent proximal tubule sodium transport requires receptor-mediated endocytosis. Am J Physiol. 1994;266:C669-C675.
31. 5 dopamine receptor regulation of NADPH oxidase and blood pressure in mice. J Am Soc Nephrol 2003;14:553A Abstract.
32. 1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anesthetized dog. J Hypertens. 1991;9:1143-1150.
33. + exchanger. Am J Physiol. 1990;258:F514-F521.
34. Sheikh-Hamad D, Wang Y-P, Jo OD, Yanagawa N. Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am J Physiol. 1993;264:F737-F743.
35. Chatziantoniou C, Ruan X, Arendshorst WJ. Defective G-protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci U S A. 1995;92:2924-2928.
36. 1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1999;34:191-198.
37. 1 dopamine receptor. Hypertension. 2003;42:438A Abstract.
38. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, Felder RA. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension. 1999;33:1036-1042.
39. Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, Sibley DR, Westphal HJ, Jose PA. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest. 1996;97:2283-2288.
40. Sanada H, Xu J, Watanabe H, Jose PA, Felder RA. Differential expression and regulation of dopamine-1 (D-1) and dopamine-5 (D-5) receptor function in human kidney. Am J Hypertens. 2000;13:156A Abstract.
41. Yang Z, Yu P, Asico LD, Wang Z, Jones JE, Bek M, Sibley DR, Jose PA. D5 dopamine receptor regulation of reactive oxygen species production and blood pressure in mice. ASH 19th Annual Scientific Meeting, New York, NY, May 18-22, 2004, Abstract 165.
42. Cheng HF, Becker BN, Burns KD, Harris RC. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest. 1995;95:2012-2019.
43. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine Ang II feedback. Am J Physiol. 1999;276:F218-F227.
44. 1 receptor and ACE binding in Ang II-induced hypertensive rats. Am J Physiol Renal Physiol. 2002;282:F19-F25.
45. Harrison-Beraard LM, Schulman IH, Raij L. Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity. Hypertension. 2003;42:1157-1163.
46. Stewen P, Mervaala E, Karppanen H, Nyman T, Saijonmaa O, Tikkanen I, Fyhrquist F. Sodium load increases renal angiotensin type 1 receptors and decreases bradykinin type 2 receptors. Hypertens Res. 2003;26:583-589.
47. Asano N, Ogura T, Mimura Y, Otsuka F, Kishida M, Hashimoto M, Yamauchi T, Makino H. Renal AT1 receptor: computerized quantification in spontaneously hypertensive rats and DOCA-salt rats. Res Commun Mol Pathol Pharmacol. 1998;100:171-180.
48. Song K, Kurobe Y, Kanehara H, Wada T, Inada Y, Nishikawa K, Miyazaki M. Mapping of angiotensin II receptor subtypes in peripheral tissues of spontaneously hypertensive rats by in vitro autoradiography. Clin Exp Pharmacol Physiol Suppl. 1995;22:S17-S19.
49. Correa FM, Viswanathan M, Ciuffo GM, Tsutsumi K, Saavedra JM. Kidney angiotensin II receptors and converting enzyme in neonatal and adult Wistar-Kyoto and spontaneously hypertensive rats. Peptides. 1995;16:19-24.
50. Matsushima Y, Kawamura M, Akabane S, Imanishi M, Kuramochi M, Ito K, Omae T. Increases in renal angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rats. J Hypertens. 1988;6:791-796.
51. Ando H, Zhou J, Macova M, Imboden H, Saavedra JM. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke. 2004;35:1726-1731.
52. Nazarali AJ, Gutkind JS, Correa FM, Saavedra JM. Enalapril decreases angiotensin II receptors in subfornical organ of SHR. Am J Physiol. 1989;256:H1609-H1614.
53. 1 receptors in normotensive and spontaneously hypertensive rats. Circulation. 2003:108;IV-153 Abstract.